Frontier Wealth Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Frontier Wealth Management’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-12,500	Closed	-$377K	–	388
2016 Q2	$377K	Buy	+12,500	New	+$254K	0.06%	242
2016 Q1	–	Sell	-40,551	Closed	-$71K	–	376
2015 Q4	$71K	Buy	+40,551	New	+$69.5K	0.01%	341

Frontier Wealth Management's CPXX Position: Q3 2016 in Review

Frontier Wealth Management sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 12,500 shares — an estimated $377K sold.

Frontier Wealth Management first reported a position in CPXX in Q4 2015 and held it in 2 quarters. The position peaked at $377K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

Frontier Wealth Management reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
Frontier Wealth Management sold 12,500 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $377K.
Frontier Wealth Management first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q4 2015 and held it in 2 quarters.
Frontier Wealth Management's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $377K in Q2 2016.
0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Frontier Wealth Management's 13F filing for Q3 2016, filed 14 Nov 2016.